multivariate analyzes

Related by string. Multivariate analyzes * Multivariate . multi variate : multivariate logistic regression . multivariate regression analysis . vitro diagnostic multivariate . multivariate statistical analysis . Multivariate logistic regression / Analyzes . ANALYZE . Analyze : Find Compare Analyze . statistical analyzes . analyze nucleic acids . collects analyzes * *

Related by context. All words. (Click for frequent words.) 78 multivariate logistic regression 78 univariate analysis 78 univariate 77 logistic regression analysis 77 multivariable analysis 77 multivariate analysis 77 univariate analyzes 76 logistic regression analyzes 76 covariates 76 covariate 75 multiple logistic regression 75 multivariate Cox 75 logistic regression model 74 multivariate regression analysis 74 Univariate 74 conditional logistic regression 74 logistic regression models 74 Multivariate analysis 73 multivariable analyzes 72 bivariate analyzes 72 bivariate 72 Univariate analysis 72 regression analyzes 72 logistic regression 72 Logistic regression 72 multivariable logistic regression 72 Poisson regression 72 stepwise logistic regression 71 Subgroup analyzes 71 prognostic factors 71 Kaplan Meier analysis 71 clinicopathological 70 sociodemographic characteristics 70 prognostic variables 70 APOE genotype 70 prostate cancer CaP 69 confidence intervals CIs 69 posttreatment 69 Multivariate logistic regression 69 tumor histology 69 MMSE score 69 multivariable Cox 69 multiple linear regression 69 postintervention 69 Multiple logistic regression 69 Subgroup analysis 69 sociodemographic factors 69 comorbidity 69 clinicopathologic 68 intraobserver 68 histological subtype 68 familial aggregation 68 ANOVA 68 Logistic regression analysis 68 HER2 expression 68 subgroup analyzes 68 proportional hazards 68 Multivariate analyzes 68 bivariate analysis 68 retrospective cohort 68 odds ratios ORs 68 sociodemographic 68 pT2 68 biochemical recurrence 68 chi squared 68 Meta analyzes 67 clinicopathological features 67 preoperative PSA 67 multivariate regression 67 MDRD 67 SNP rs# [002] 67 nonparametric 67 multivariate adjustment 67 potential confounders 67 sociodemographic variables 67 Regression analyzes 67 pCR 67 genotypic resistance 67 sleeve lobectomy 67 allele frequencies 67 Kaplan Meier curves 67 multivariable adjusted 67 spirometric 67 MetS 67 EQ 5D 67 confounding variables 67 interobserver 67 adiponectin concentrations 67 ANCOVA 67 mammographic density 67 nodal metastasis 66 rs# [004] 66 meta regression 66 nodal metastases 66 Bonferroni correction 66 CORE OM 66 hormone receptor status 66 tertiles 66 histopathologic 66 confounders 66 carotid IMT 66 proband 66 psychiatric comorbidity 66 TT genotype 66 CYP#D# genotype 66 FDG PET imaging 66 IL#B 66 convergent validity 66 generalized estimating 66 comorbidities 66 prognostic indicators 66 serum concentrations 66 BMI z 66 pT3 66 F FDG PET 66 serum estradiol 66 prospectively defined 66 interobserver reliability 66 affective psychosis 66 IPAH 66 NHANES III 66 meta analytic 66 intima media thickness 66 histopathological 66 confounder 66 Bonferroni 65 histologic subtype 65 Kaplan Meier method 65 transrectal ultrasound guided 65 nondiabetic patients 65 fraternal twin pairs 65 autonomic dysfunction 65 oncologic outcomes 65 comorbid depression 65 immunostaining 65 intact parathyroid hormone 65 etiologic 65 virological response 65 rs# [001] 65 depressive symptomatology 65 nomograms 65 baseline LDH 65 explanatory variables 65 randomized controlled trials RCTs 65 lymphovascular invasion 65 differential gene expression 65 atypical hyperplasia 65 clinico pathological 65 pretransplant 65 echocardiographic parameters 65 monozygotic 65 haematologic 65 bone scintigraphy 65 thyrotropin levels 65 Descriptive statistics 65 pancreatic adenocarcinoma 65 immunohistochemical analysis 65 extramedullary 65 urothelial carcinoma 65 core needle biopsies 65 Histologic 65 tipranavir ritonavir 65 comorbid disorders 65 linear regression analyzes 65 comorbid conditions 65 variance ANOVA 65 Preoperatively 65 Kaplan Meier survival 64 ABCB1 64 HRCT 64 logistic regressions 64 lymph node metastasis 64 CR nPR 64 NMIBC 64 parous women 64 multivariable 64 Kruskal Wallis test 64 operable breast cancer 64 liver transplant recipients 64 thyroglobulin 64 prostate carcinoma 64 symptomatic VTE 64 microsatellite instability 64 TOP2A 64 preoperative chemotherapy 64 RRM1 64 #F FDG PET 64 SLNB 64 immunohistochemical 64 CIN2 + 64 psychiatric comorbidities 64 adjuvant systemic 64 colorectal adenoma 64 scintigraphic 64 differentially expressed genes 64 K ras mutations 64 PCa 64 somatoform disorders 64 HRQL 64 metabolite concentrations 64 electrophysiologic 64 COMT genotype 64 transvaginal sonography 64 euthymic patients 64 hierarchical clustering 64 DAS# scores 64 kidney allograft 64 immunohistochemical staining 64 binary logistic regression 64 FDG-PET/CT 64 tumor subtype 64 adenotonsillectomy 64 tertile 64 HER2 overexpression 64 subscale scores 64 SLN biopsy 64 symptomatic intracerebral hemorrhage 64 susceptibility loci 64 cranial irradiation 64 angiographically 64 HOMA IR 64 probands 64 specific antigen PSA 64 pairwise comparisons 64 airway responsiveness 64 interrater reliability 64 methacholine challenge 64 obstructive coronary artery 64 estimated GFR 64 plasma cortisol 64 advanced neoplasia 64 nonmetastatic 64 elevated LDH 64 MDRD equation 64 mRNA expression 64 biochemical relapse 64 histologic subtypes 64 locoregional recurrence 64 EuroSCORE 63 % CI #.#-#.# [006] 63 endometrial carcinoma 63 nonpregnant women 63 PSADT 63 Sociodemographic 63 CC genotype 63 gene polymorphisms 63 HRQOL 63 posttest 63 hematopoietic cancers 63 comorbid anxiety 63 PSA nadir 63 histologically confirmed 63 % CI #.#-#.# [008] 63 β blockers 63 affective disorders 63 myocardial viability 63 histologic 63 Reynolds Risk Score 63 hepatocellular carcinomas 63 serum creatinine levels 63 pretest probability 63 neurocognitive function 63 genetic polymorphisms 63 karyotypes 63 estrogen receptor ER 63 mucinous 63 pelvic lymphadenectomy 63 DAS# CRP 63 alexithymia 63 node metastases 63 unmeasured confounders 63 premorbid 63 intravesical therapy 63 Kaplan Meier curve 63 plasma pharmacokinetics 63 virologic responses 63 androgen suppression 63 retrospective cohort study 63 adrenalectomy 63 glomerular filtration rate 63 seropositivity 63 underwent resection 63 covariance ANCOVA 63 EGFR mutation status 63 % CI #.#-#.# [003] 63 nonpsychotic 63 metabolic parameters 63 HSCT 63 completely resected 63 lymphocyte count 63 albumin excretion rate 63 Pearson correlation coefficients 63 Mantel Haenszel 63 CIN3 63 CVD mortality 63 KRAS mutations 63 postoperative mortality 63 radical prostatectomy RP 63 T1a 63 breast carcinoma 63 coinfected patients 63 VADT 63 Oncotype DX Recurrence Score 63 PSQI 63 System IPSS 63 antiretroviral naïve 63 advanced adenomas 63 adenoma recurrence 63 Baseline characteristics 63 HNSCC 63 hip resurfacing arthroplasty 63 MR spectroscopy 63 radical cystectomy 63 cytologic 63 AST ALT 63 nondepressed 63 platelet reactivity 63 allelic 63 generalized linear 63 extensive metabolizers 63 cTnI 63 LV dysfunction 63 NIHSS 63 Socioeconomic status 63 histologically proven 63 KRAS mutation 63 T2DM 63 UGT#A# * 63 advanced adenoma 62 depressive symptom 62 P = .# 62 syndromal 62 coronary stenosis 62 estimated glomerular filtration 62 biopsy Gleason 62 neurocognitive impairment 62 urodynamic 62 Heritability 62 perioperative complications 62 urine cytology 62 #q# deletion syndrome 62 postoperative chemotherapy 62 invasive ductal 62 prognostic significance 62 postoperative complication 62 ELBW infants 62 VKORC1 62 multivariable adjustment 62 lymph node involvement 62 % CI #.#-#.# [007] 62 nulliparous women 62 predictive validity 62 Recurrence Score 62 cerebral microbleeds 62 prespecified secondary 62 serum lipid levels 62 Socio demographic 62 potential confounding variables 62 gadolinium enhanced 62 Histological 62 Multivariable logistic regression 62 neoadjuvant chemotherapy 62 Comorbidity 62 periprocedural 62 albumin excretion 62 baseline HbA1c 62 subclinical hyperthyroidism 62 Doxil ® 62 radiochemotherapy 62 nonobese 62 preintervention 62 FEV ^ sub 62 C#BL/#J mice 62 APOE ε4 62 Charlson comorbidity index 62 ASCUS 62 SNP rs# [001] 62 metastatic lymph nodes 62 inhibin B 62 p = .# [002] 62 histopathologic diagnosis 62 anthropometric measurements 62 incomplete revascularization 62 psychiatric morbidity 62 elevated ALT 62 heterozygotes 62 BRCA2 mutation carriers 62 breast cancer subtypes 62 perinatal outcomes 62 Rating Scale BPRS 62 paricalcitol 62 transient elastography 62 femoral neck BMD 62 renal cysts 62 NNRTI resistance 62 neoadjuvant 62 definite stent thrombosis 62 ultrasonographic 62 undetectable HBV DNA 62 NYHA functional class 62 NIHSS score 62 chest radiographs 62 adnexal mass 62 SUVmax 62 posttransplant 62 cystatin C 62 extracapsular extension 62 serum GGT 62 subscales 62 cortical activation 62 missense mutations 62 transabdominal 62 Cytogenetic 62 microRNA expression 62 contralateral breast cancer 62 fasting insulin 62 LAGB 62 liver histology 62 Multiple linear regression 62 TEAEs 62 HRQoL 62 tHcy 62 FDG PET 62 SCr 62 shorter telomere length 62 Child Behavior Checklist 62 aldosterone antagonist 62 antioxidant supplementation 62 HIV HCV coinfected 62 subscores 62 FDG uptake 62 TIMP 1 62 metaanalysis 62 poor metabolizers 62 MMSE scores 62 seminal vesicle invasion 62 #q# deletion 62 bronchoalveolar lavage 62 bladder carcinoma 62 prospective longitudinal 62 lymphadenectomy 62 ROC curves 62 relapsed MM 62 neurosensory 62 lowest tertile 62 % CI #.#-#.# [005] 62 physiologic parameters 62 F FDG uptake 62 subclinical atherosclerosis 62 radical nephrectomy 62 monozygotic twin 62 metaplasia 62 Cardiorespiratory fitness 62 liver metastasis 61 mammographically 61 adjuvant radiotherapy 61 MGUS 61 QTc prolongation 61 attain statistical significance 61 Response Evaluation Criteria 61 EUS FNA 61 KRAS status 61 perioperative morbidity 61 demographic variables 61 neoplasias 61 TNM staging 61 Comorbidities 61 genetic loci 61 nomogram 61 HER2 amplification 61 Tumor Response 61 retrospective observational study 61 linear regression analysis 61 detrusor overactivity 61 prognostic factor 61 prospective observational studies 61 FDG PET scans 61 PCWP 61 Main Outcome Measures 61 Secondary efficacy endpoints 61 nonfatal MI 61 correlation coefficients 61 endometrial thickness 61 Brief Psychiatric 61 prospective multicenter study 61 exploratory endpoints 61 familial clustering 61 SGAs 61 adenoidectomy 61 glycosylated hemoglobin HbA1c 61 progesterone receptor PR 61 squamous histology 61 serous ovarian cancer 61 semiquantitative 61 Cystatin C 61 recurrent glioblastoma multiforme 61 CYP#D# inhibitor 61 residual confounding 61 leukocyte counts 61 morphometric vertebral fractures 61 hip BMD 61 invasive lobular 61 postdischarge 61 lymph node metastases 61 thiopurine 61 HbA 1c levels 61 antiangiogenic therapy 61 isoprostane 61 inotropic agents 61 serum PSA 61 gastric cardia 61 chlamydial infection 61 salivary cortisol 61 laterality 61 response pCR 61 prevalences 61 genomewide 61 adjuvant therapies 61 hepatic cirrhosis 61 distant metastasis 61 extracolonic findings 61 tipranavir r 61 erection hardness 61 intraclass correlation coefficients 61 inflammatory biomarkers 61 IGRAs 61 hematological relapse 61 induced sputum 61 comorbid 61 troponins 61 BEXXAR Therapeutic Regimen 61 duplex ultrasonography 61 hepatic lesions 61 subthreshold 61 somatic mutations 61 observational cohort study 61 monozygotic twins 61 suicide attempters 61 Linear regression 61 histologically 61 Index CDAI 61 Kaplan Meier 61 allogeneic transplant 61 Pearson correlation coefficient 61 HBeAg negative 61 antibody titer 61 rs# [002] 61 transgene expression 61 LV ejection fraction 61 cTnT 61 miRNA expression 61 patients undergoing CABG 61 mutated K ras 61 qRT PCR 61 histopathologic examination 61 carotid stenosis 61 Postoperative complications 61 transthoracic 61 recursive partitioning 61 nonfasting triglyceride levels 61 abdominal adiposity 61 clinically localized prostate 61 normal karyotype 61 PCA3 scores 61 DAS# remission 61 CYP#D# gene 61 CHD mortality 61 Zevalin consolidation 61 adverse perinatal 61 telomere lengths 61 somatic symptoms 61 serum albumin 61 retrospectively analyzed 61 histopathologic findings 61 hsCRP levels 61 sonographic findings 61 primary aldosteronism 61 genotypic 61 neuroimaging studies 61 radiotherapy RT 61 T1c 61 subscore 61 pharmacokinetic interaction 61 prognostic markers 61 postoperative radiotherapy 61 methotrexate therapy 61 abnormal cytology 61 FeNO 61 polygenic 61 radical retropubic prostatectomy 61 immunoreactivity 61 adenoma detection 61 WOMAC scores 61 VNTR 61 rheumatoid factor 61 subanalysis 61 dosimetric 61 genotype phenotype 61 CTEPH 61 serum vitamin D 61 DNA methylation patterns 61 cognitive affective 61 sensitivity specificity 61 MADIT CRT trial 61 coronary calcification 61 HBeAg 61 Immunohistochemical staining 61 serum cortisol 61 Gram stain 60 sonographically guided 60 p = #.# [003] 60 Immunohistochemical analysis 60 Ki# 60 penetrance 60 Interrater reliability 60 highest tertile 60 anti Mullerian hormone 60 Multivariate 60 promoter methylation 60 Supplementary Table 60 locoregional 60 potentially confounding variables 60 baseline FEV 60 PTPN# 60 ECOG PS 60 hormone receptor negative 60 mRS 60 TP# mutations 60 BPS IC 60 regression equations 60 VATS lobectomy 60 nondemented 60 chi ^ sup 60 sarcomatoid 60 methotrexate monotherapy 60 perioperative mortality 60 aneuploidy screening 60 hematological parameters 60 dopamine receptor gene 60 statistically nonsignificant 60 chronicity 60 EBRT 60 Lymph node 60 diabetes mellitus DM 60 CD# expression [002] 60 CsA 60 pathologic examination 60 APOE e4 60 dyads 60 plain radiographs 60 histological subtypes 60 comorbid diagnoses 60 ERBB2 60 airway hyperresponsiveness 60 debulking surgery 60 gallstone disease 60 antenatal depression 60 BRCA1 BRCA2 60 aortic calcification 60 inferential statistics 60 trials RCTs 60 -#.# ± [002] 60 epistasis 60 urine albumin 60 invasive carcinoma 60 #OHD 60 APACHE II 60 ductal breast cancer 60 methylation patterns 60 variant allele 60 cystectomy 60 dose atorvastatin 60 hepatic fibrosis 60 KIF6 carriers 60 microalbumin 60 virologic failure 60 TURBT 60 autologous SCT 60 Primary endpoints 60 tumor necrosis 60 neuropsychological assessment 60 Regression analysis 60 eNO 60 BI RADS 60 papillary renal cell carcinoma 60 esophageal carcinoma 60 OGTT 60 cisplatin resistant 60 hamartomas 60 unpaired t 60 Preoperative 60 nephron sparing surgery 60 radiographic findings 60 epithelial tumors 60 hemoglobin Hb 60 BRCA testing 60 thyroid carcinoma 60 lignan intake 60 psychometric properties 60 microvessel density 60 serologic tests 60 histologic findings 60 core needle biopsy 60 QoL 60 postmenopausal hormone 60 Depressive symptoms 60 sentinel lymph node biopsy 60 CCyR 60 homocysteine concentrations 60 serum markers 60 T1DM 60 Main Outcome Measure 60 neoadjuvant therapy 60 renal cell carcinomas 60 LHRH receptor positive 60 dyslipidaemia 60 serum lactate 60 Symptom severity 60 Charlson Comorbidity Index 60 preoperatively 60 colorectal neoplasia 60 Operative mortality 60 chemoradiation therapy 60 SF #v# 60 efficacy evaluable 60 serum testosterone 60 renal tumors 60 Multivariable 60 carotid plaques 60 distant metastases 60 socioeconomic variables 60 correlational 60 HIV RNA 60 calculated creatinine clearance 60 COL#A# 60 vesicoureteral reflux 60 statistically significant correlation 60 invasive carcinomas 60 thyrotropin 60 progesterone receptor negative 60 rCBF 60 RASSF1A 60 ADAS cog 60 stratifying patients 60 Renal Cell Carcinoma RCC 60 psychosocial variables 60 FOLPI 60 amisulpride 60 impaired glucose metabolism 60 Estrogen Receptor 60 Sprague Dawley rats 60 nonsignificant 60 DRD2 60 carotid artery thickness 60 electroencephalographic 60 neurophysiologic 60 RECIST Response Evaluation Criteria 60 empiric 60 lipid lowering agents 60 Postoperative 60 subclinical hypothyroidism 60 cTnT levels 60 socioeconomic status SES 60 perfusion abnormalities 60 mL/min/#.# m 2 60 prognostic biomarker 60 preoperative diagnosis 60 molecular subtypes 60 Microarray analysis 60 DSM IV diagnosis 60 PITX2 60 colorectal neoplasms 60 neurodevelopmental impairment 60 elevated troponin 60 timepoints 60 HBeAg negative patients 60 malignant lesions 60 TMPRSS2 ERG fusion 60 confidence interval CI 60 creatinine ratio 60 somatization disorder 60 T2 lesions 60 dimensional echocardiography 60 doxorubicin docetaxel 60 seronegative 60 visceral metastases 60 surrogate markers 60 chemoprevention trials 60 external beam radiotherapy 60 neuropathologic 60 SSRI citalopram 60 multivariate 60 conventional angiography 60 behavioral disinhibition 60 OPCAB 60 syndromic 60 ECLS 60 apolipoprotein B 60 lumbar spine BMD 60 BRCA1 mutation carriers 60 unfavorable prognostic 60 perioperatively 60 Breslow thickness 60 Histopathological 60 Montgomery Åsberg Depression 60 phylogenetic analyzes 60 noncardiac 60 gastric carcinoma 60 fluorodeoxyglucose positron emission tomography 60 ELISPOT 60 underwent surgical resection 60 ischemic lesions 59 axillary lymph nodes 59 Kaplan Meier estimates 59 variant rs# 59 authors hypothesized 59 nonobese patients 59 nonrandomized 59 HGPIN 59 serum BDNF 59 plasma lipid 59 elevated CRP 59 DAS# [002] 59 hemoglobin A1c levels 59 confidence interval #.#-#.# 59 Suicidal ideation 59 Incontinence Impact Questionnaire 59 BRAF V#E mutation 59 median survivals 59 RE LY trial 59 MTT assay 59 serum cotinine 59 serum prostate 59 microarray experiments 59 statistical significance p 59 ABL1 59 gene polymorphism 59 polytherapy 59 transcranial Doppler 59 BCR ABL mutations 59 K#N 59 PITX2 methylation 59 clomipramine 59 schizophreniform disorder 59 paclitaxel eluting stents 59 atrioventricular block 59 glomerular filtration 59 trastuzumab Herceptin ® 59 inhaled corticosteroid therapy 59 IDH1 mutation 59 bronchoalveolar lavage BAL 59 virologic response 59 axillary node dissection 59 reflux esophagitis 59 preeclamptic 59 RT PCR assay 59 hydroxyvitamin D levels 59 Pharmacokinetic parameters 59 International Prognostic Scoring 59 CT urography 59 Genotypic 59 congenital toxoplasmosis 59 chorioamnionitis 59 μmol L 59 TKAs 59 apolipoproteins 59 dizygotic twins 59 pentoxifylline 59 prospective multicentre 59 contralateral breast 59 SLC#A# [002] 59 leiomyomas 59 hMG 59 Hurthle cell 59 nonrandomized studies 59 Cognitive impairment 59 predictor variables 59 endoscopic ultrasonography 59 psychosocial functioning 59 CI -#.# 59 interquartile range 59 5 HTTLPR 59 exhaled nitric oxide 59 regression coefficient 59 GnRH agonists 59 genomic alterations 59 subtrochanteric 59 LUTS 59 salpingo oophorectomy 59 ADRB2 59 pathologic 59 maternal serum 59 nonexposed 59 periprocedural MI 59 hemodynamic parameters 59 micafungin 59 inotropic 59 morphologic 59 fosamprenavir 59 bronchoalveolar lavage fluid 59 atherothrombotic 59 thrombophilia 59 fluvastatin 59 Lp PLA 2 59 Insulin sensitivity 59 pharmacodynamic parameters 59 serum leptin 59 ER CHOP 59 psychiatric outpatients 59 CLBP 59 eculizumab therapy 59 eosinophil count 59 TMPRSS2 ERG 59 statistically significant correlations 59 elevated fasting glucose 59 HIV uninfected 59 transesophageal 59 MTHFR 59 epithelial ovarian cancer 59 hsCRP 59 histologies 59 Serum creatinine 59 covariance 59 serum calcium 59 nonpharmacologic 59 SpCO 59 serum urate levels 59 postoperative morbidity 59 underwent coronary angiography 59 transcranial Doppler ultrasound 59 lobular carcinoma 59 varicoceles 59 ERalpha 59 HbA1C levels 59 tumor subtypes 59 proton MR spectroscopy 59 linear regressions 59 dose Iluvien 59 C. trachomatis 59 Histopathologic 59 symptom exacerbation 59 Solid Tumors RECIST 59 nonresponders 59 NAMCS 59 monoinfected patients 59 BMD measurements 59 ECOG 59 resected pancreatic cancer 59 RCTs 59 Papillary 59 EURIDIS 59 diastolic pressures 59 androgen deprivation 59 gene expression profiles 59 CI #.#-#.# [001] 59 monoclonal gammopathy 59 SE alleles 59 elevated creatinine 59 Y BOCS 59 callous unemotional traits 59 inhospital mortality 59 ADCS CGIC 59 fetal malformations 59 hematologic toxicity 59 chromosome #p# [002] 59 thyroid hormone levels 59 titrated glipizide 59 Non inferiority 59 varicocele 59 PLMs 59 QIDS SR 59 preserved ejection fraction 59 carotid plaque 59 APTIVUS r 59 abacavir Ziagen 59 Immunohistochemistry 59 sCJD 59 Randomized trials 59 iodixanol 59 nonalcoholic steatohepatitis NASH 59 concurrent chemoradiation 59 neutropaenia 59 nucleotide substitutions 59 CHADS2 59 fractional anisotropy 59 Framingham Offspring 59 chemosensitivity 59 visceral adiposity 59 vitro experiments 59 elevated serum creatinine 59 Observational studies 59 RQ PCR 59 serum HBV DNA 59 Randomized clinical trials 59 retest reliability 59 lipid abnormalities 59 SGRQ 59 metabolomic profiles 59 antihypertensive therapy

Back to home page